Trial intelligence / Profile preview

Dopamine for renal function protection in diabetic patients undergoing cardiac surgery

IRCT2015110823716N1Phase 3Completed

Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sc
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dopamine in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Vice Chancellor for Research, Shiraz University of Medical Sc. Started Feb 2016; status: completed.

02

Drugs

dopamine
03

Conditions

diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT2015110823716N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015110823716N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call